MX9305152A - Metodo para el tratamiento de enfermedades obstructivas y reversibles de las vias respiratorias. - Google Patents

Metodo para el tratamiento de enfermedades obstructivas y reversibles de las vias respiratorias.

Info

Publication number
MX9305152A
MX9305152A MX9305152A MX9305152A MX9305152A MX 9305152 A MX9305152 A MX 9305152A MX 9305152 A MX9305152 A MX 9305152A MX 9305152 A MX9305152 A MX 9305152A MX 9305152 A MX9305152 A MX 9305152A
Authority
MX
Mexico
Prior art keywords
obstructive
respiratory tract
treatment
diseases
reversible
Prior art date
Application number
MX9305152A
Other languages
English (en)
Spanish (es)
Inventor
Catherine Hallam
Stephen Thomas Harper
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of MX9305152A publication Critical patent/MX9305152A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX9305152A 1992-08-25 1993-08-25 Metodo para el tratamiento de enfermedades obstructivas y reversibles de las vias respiratorias. MX9305152A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929218027A GB9218027D0 (en) 1992-08-25 1992-08-25 Novel method of treatment

Publications (1)

Publication Number Publication Date
MX9305152A true MX9305152A (es) 1994-05-31

Family

ID=10720906

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9305152A MX9305152A (es) 1992-08-25 1993-08-25 Metodo para el tratamiento de enfermedades obstructivas y reversibles de las vias respiratorias.

Country Status (6)

Country Link
AU (1) AU4967193A (xx)
GB (1) GB9218027D0 (xx)
IL (1) IL106751A0 (xx)
MX (1) MX9305152A (xx)
WO (1) WO1994004148A1 (xx)
ZA (1) ZA936137B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP223198A0 (en) * 1998-03-06 1998-04-02 Fujisawa Pharmaceutical Co., Ltd. New use
GB9917158D0 (en) * 1999-07-21 1999-09-22 Fujisawa Pharmaceutical Co New use
PT1666028E (pt) 1999-10-29 2010-06-15 Novartis Ag Composições de pós anidros com melhor dispersividade
US6878751B1 (en) * 2000-10-19 2005-04-12 Imperial College Of Science Technology And Medicine Administration of resveratrol to treat inflammatory respiratory disorders
AR035411A1 (es) * 2000-12-29 2004-05-26 Fujisawa Pharmaceutical Co Uso de un derivado de tacrolimus para fabricar un agente neurotrofico, composiciones y articulos de fabricacion o kits que lo comprenden, metodo para fabricar un agente que lo comprende y tejidos e injertos con una celula nerviosa tratada con este compuesto
JP2007518692A (ja) * 2004-01-20 2007-07-12 アステラス製薬株式会社 勃起不全治療方法
MX2019005504A (es) 2016-11-10 2019-08-12 Novartis Ag Potenciadores de bmp.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU630866B2 (en) * 1987-12-09 1992-11-12 Fisons Plc Macrocyclic compounds
IE64214B1 (en) * 1989-06-06 1995-07-26 Fujisawa Pharmaceutical Co Macrolides for the treatment of reversible obstructive airways diseases
GR1001225B (el) * 1989-09-14 1993-06-30 Fisons Plc Νέαι μακροκυκλικαί ενώσεις και νέα μέ?οδος χρήσεως τους.
CA2054983A1 (en) * 1990-11-08 1992-05-09 Sotoo Asakura Suspendible composition and process for preparing the same

Also Published As

Publication number Publication date
WO1994004148A1 (en) 1994-03-03
ZA936137B (en) 1994-02-21
GB9218027D0 (en) 1992-10-14
AU4967193A (en) 1994-03-15
IL106751A0 (en) 1993-12-08

Similar Documents

Publication Publication Date Title
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
BR9906581A (pt) Processo para administração de taxano encapsulado em lipossomos
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
BR9710372A (pt) Composto composi-Æo farmac-utica e processos para o tratamento de uma doen-a inflamatÄria e de doen-as mediadas pela cliclooxigenase
BR0008276A (pt) Combinações de formoterol e propionato de fluticasona para asma
BR9406979A (pt) Composto,composicão farmaceutica para tratar uma doenca inflamatória suscetivel de tratamento com um agente anti- inflamatório nao esteroidal processos para tratar uma doenca inflamatória e para preparar um composto sal famacéuticamente aceitável uso de um composto composicão farmaceutica anti-inflamatória nao esteroidal
NO20022014D0 (no) Kontrollert frigjöring av hydrocodone formuleringer
BR9808812A (pt) Composição compreendendo partìculas cristalinas, finamente divididas de budesonida
AR243381A1 (es) Procedimiento de obtencion de una composicion farmaceutica para la prevencion de enfermedades que se pueden transmitir por via sexual.
DE69429202T2 (de) Therapeutischer Wirkstoff für Erkrankungen des Verdauungstraktes
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
ES2145818T3 (es) Utilizacion de la (s)-(-)-alfa-etil-2-oxo-1-pirrolidin-acetamida para la preparacion de medicamentos destinados al tratamiento de la ansiedad.
BR9611555A (pt) Compostos formulação farmacêutica utilização de um composto processo para tratamento de uma doença obstrutiva reversível das vias aéreas e para preparação do composto
AR010984A1 (es) Nuevos esteres de la pleuromutilina, y el acido 1-azabiciclo-4- carbanilcarbanico; procedimiento para su preparacion y composicionesfarmaceuticas que los contienen.
MX9305152A (es) Metodo para el tratamiento de enfermedades obstructivas y reversibles de las vias respiratorias.
ES2079832T3 (es) Acido quenodeoxicolico o acido ursodeoxicolico para el tratamiento de enfermedades de los organos respiratorios.
AR018347A1 (es) 1h-indazoles 1,5 y 3-o-sustituidos y sus sales fisiologicamente tolerables, utilizacion de los mismos para la preparacion de medicamentos, procedimientospara preparar dichos compuestos, las composiciones y preparaciones farmaceuticas que los contienen, y la utilizacion de dichos compuestos y prepara
ITMI910456A0 (it) Composizione farmaceutica per il trattamento della cataratta
IT1151953B (it) Composizione farmaceutica per la cura di affezioni della cavita' orale
NO961797D0 (no) Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter
IT1241079B (it) Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
BR9407862A (pt) Composto de flavina flavina derivado de flavina ou uma mistura que compreende duas ou mais destas composiçao farmacêutica e processo para o tratamento por profilaxia ou terapia de doença causada por infecçao virótica
ID21369A (id) Komposisi farmasi untuk penyembuhan penyakit yang disebabkan oleh virus
ES2101311T3 (es) Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer.
ES2161809T3 (es) Uso de factor proliferativo osteoblastico.